Sana biotechnology to present at the goldman sachs 43rd annual global healthcare conference

Seattle, june 07, 2022 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the goldman sachs 43rd annual global healthcare conference at 4:00 p.m. pt on tuesday, june 14, 2022. the presentation will feature a business overview and update by steve harr, sana's president and chief executive officer.
SANA Ratings Summary
SANA Quant Ranking